private beta
search about

Assistant Professor of Biostatistics at @UF specializing in emerging infectious diseases and vaccine study design. @HarvardBiostats PhD. Tweets my own. She/her.

Jun 15, 2020 4:30 PM
copied to clipboard

HCQ should never have received an Emergency Use Authorization, which is too easily conflated with the idea that “FDA says it works.” The original decision was decried by former FDA leaders, and stood in contrast with EMA’s approach. From me in April: https://www.washingtonpost.com/outlook/coronavirus-hydroxychloroquine-trials-research/2020/04/10/fa003ada-7a7a-11ea-a130-df573469f094_story.html

Helen Branswell (@HelenBranswell):
.@US_FDA rescinds emergency use authorizations for hydroxychloroquine, which has not proved to be useful against #Covid19. https://t.co/u1bFGV9Itf

Relevant excerpt from my Perspective piece in @PostOutlook plus links: https://www.sciencemag.org/news/2020/04/former-fda-leaders-decry-emergency-authorization-malaria-drugs-coronavirus https://www.ema.europa.eu/en/news/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes

tweet media